These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12524215)

  • 1. Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism?
    Loscalzo J
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):3-5. PubMed ID: 12524215
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice.
    Chen J; Kuhlencordt P; Urano F; Ichinose H; Astern J; Huang PL
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):97-103. PubMed ID: 12524231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis.
    Laufs U; Wassmann S; Czech T; Münzel T; Eisenhauer M; Böhm M; Nickenig G
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):809-14. PubMed ID: 15692095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobiopterin: mediator of endothelial protection.
    Katusic ZS; d'Uscio LV
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):397-8. PubMed ID: 15003973
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of the nitric oxide synthase pathway in atherosclerosis.
    Maxwell AJ; Tsao PS; Cooke JP
    Exp Physiol; 1998 Sep; 83(5):573-84. PubMed ID: 9793778
    [No Abstract]   [Full Text] [Related]  

  • 6. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity.
    d'Uscio LV; Milstien S; Richardson D; Smith L; Katusic ZS
    Circ Res; 2003 Jan; 92(1):88-95. PubMed ID: 12522125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants and the bioactivity of endothelium-derived nitric oxide.
    Tomasian D; Keaney JF; Vita JA
    Cardiovasc Res; 2000 Aug; 47(3):426-35. PubMed ID: 10963716
    [No Abstract]   [Full Text] [Related]  

  • 9. L-arginine and atherothrombosis.
    Loscalzo J
    J Nutr; 2004 Oct; 134(10 Suppl):2798S-2800S; discussion 2818S-2819S. PubMed ID: 15465788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.
    Ignarro LJ; Napoli C
    Curr Diab Rep; 2005 Feb; 5(1):17-23. PubMed ID: 15663912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters.
    Closs EI; Scheld JS; Sharafi M; Förstermann U
    Mol Pharmacol; 2000 Jan; 57(1):68-74. PubMed ID: 10617680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine increases plasma homocysteine in apoE-/-/iNOS-/- double knockout mice.
    Handy DE; Scolaro J; Chen J; Huang P; Loscalzo J
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):903-9. PubMed ID: 15704254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of endothelial nitric oxide synthase and atherosclerosis.
    Kawashima S; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice.
    von der Thüsen JH; van Berkel TJ; Biessen EA
    Circulation; 2001 Feb; 103(8):1164-70. PubMed ID: 11222482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.
    Kuhlencordt PJ; Chen J; Han F; Astern J; Huang PL
    Circulation; 2001 Jun; 103(25):3099-104. PubMed ID: 11425775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice.
    Hodgin JB; Knowles JW; Kim HS; Smithies O; Maeda N
    J Clin Invest; 2002 Feb; 109(4):541-8. PubMed ID: 11854327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis and the two faces of endothelial nitric oxide synthase.
    Wever RM; Lüscher TF; Cosentino F; Rabelink TJ
    Circulation; 1998 Jan 6-13; 97(1):108-12. PubMed ID: 9443438
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
    Bode-Böger SM
    Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of dietary L-arginine supplementation.
    Preli RB; Klein KP; Herrington DM
    Atherosclerosis; 2002 May; 162(1):1-15. PubMed ID: 11947892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice.
    d'Uscio LV; Baker TA; Mantilla CB; Smith L; Weiler D; Sieck GC; Katusic ZS
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1017-22. PubMed ID: 11397713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.